Showing results (301-310 of 323) with videos related to

Sort By:
Pageof 33
Cancer|March 20, 1998
A multifaceted study of human papillomavirus and prostate carcinomaH D Strickler, R Burk, K Shah, et al.
Tumori|March 18, 1999
The role of radiotherapy in the treatment of carcinoma of the prostate: a survey of clinical practices in Lombardy, Italy, by the AIRO-Lombardia Cooperative Group. Italian Association for Radiation OncologyS Villa, F Bertoni, A Bossi, et al.
Cancer Research|May 15, 1996
Multidrug resistance and malignancy in human osteosarcomaK Scotlandi, M Serra, G Nicoletti, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2008
Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumoursS Cresta, C Sessa, C V Catapano, et al.
Human Mutation|November 4, 2004
Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150CLeida B Rozeman, Luca Sangiorgi, Inge H Briaire-de Bruijn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2015
Histologic transformation in marginal zone lymphomas†A Conconi, S Franceschetti, K Aprile von Hohenstaufen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2013
Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISHM Mian, A Rinaldi, A A Mensah, et al.
Placenta|July 12, 2008
Somatostatin as a regulator of first-trimester human trophoblast functionsC Biondi, M E Ferretti, L Lunghi, et al.
Tumori|April 25, 2000
Nonmetastatic osteosarcoma of the extremity: results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intraarterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor responseS Ferrari, M Mercuri, P Picci, et al.
Leukemia|May 19, 2009
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21D Rossi, S Rasi, S Franceschetti, et al.
Pageof 33